Home » Topics » Disease categories and therapies » Infection

Infection
RSS

Pfizer produces novel erythromycins using precursor-directed biosynthetic technology

Dec. 10, 1998

Micrologix Biotech initiates phase I trial in U.S. with MBI-226

Dec. 10, 1998

LY-303366: therapeutic and prophylactic efficacy in pulmonary aspergillosis in neutropenic animals

Dec. 9, 1998

Water-soluble antifungal agents enter the pipeline at Takeda

Dec. 8, 1998

Japanese lab prepares new, broad-spectrum carbapenems

Dec. 7, 1998

Potent antifungal triazoles reported by Sankyo

Dec. 7, 1998

Potent anti-MRSA agents developed by Sankyo

Dec. 4, 1998

Ascent to terminate copromotion agreement with Bristol-Myers Squibb

Dec. 4, 1998

Ascent to promote Warner-Lambert's Omnicef

Dec. 3, 1998

Bausch & Lomb to manufacture Lidakol for treatment of oral-facial herpes

Dec. 3, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 10, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026